Publication | Closed Access

Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4

HepatologyHepatocellular CarcinomaMedicineLiver PhysiologyOncogenic AgentPathologyLiver CancerReactive Oxygen SpeciesCell BiologyTumor MicroenvironmentOxidative StressGlucose-dependent Alterations